Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Not sure how to tackle the task of writing about your intervention? IHIP can help.News Article updated on 01/27/2023
-
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
PrEP Policies and Programs Help End the HIV Epidemic
Summary of pre-exposure prophylaxis (PrEP) provisions under HRSA and the Ryan White HIV/AIDS Program and PrEP resources on coverage and costs and providers with PrEP expertise.
Blog updated 11/14/2023
-
A Look Back Blog: Negotiating with Health Plans
A 2014 blog on how a Ryan White HIV clinic negotiated with a health plan, with lessons learned for agencies seeking coverage for the new treatment long-acting injectables.
Blog updated 03/25/2024
-
The Evolution of Ryan White HIV Care
Cross-post of a guest editorial by Dr. Laura Cheever, HRSA Associate Administrator for HIV/AIDS, from Leading with Race, NMAC.
Blog updated 01/07/2021
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
Toolkit Features State Strategies to Improve the Health of People with HIV
HHS has supported development of a toolkit on state Medicaid and health department coordination to improve HIV care delivery.
Blog updated 12/28/2022
-
Now Open: Register and Exhibit at 2024 Ryan White Conference
Register and Exhibit at 2024 Ryan White Conference.News Article updated on 02/14/2024 -
Funding Opportunity for HRSA Health Centers: Care Transitions for People Leaving Incarceration
"The Health Resources and Services Administration (HRSA) has announced the availability of $51 million for HRSA-funded health centers to implement innovative approaches to support transitions in care for people leaving incarceration.News Article updated on 05/03/2024 -
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024